康华生物股价上涨3.03% 上海国资战略控股加速疫苗布局

Group 1 - The latest stock price of Kanghua Biotech is 86.24 yuan, an increase of 2.54 yuan or 3.03% from the previous trading day. The intraday high reached 87.52 yuan and the low was 83.70 yuan, with a trading volume of 527 million yuan and a turnover rate of 5.13% [1] - Kanghua Biotech operates in the biopharmaceutical sector, focusing on the research, production, and sales of human vaccines. Its main products include rabies vaccines and Japanese encephalitis vaccines, and the company is actively expanding into the pet vaccine market [1] - The Shanghai Biopharmaceutical M&A Fund strategically took control of Kanghua Biotech in July, with plans to accelerate the diversification of the vaccine product line and build a vaccine ecosystem. This collaboration is seen as a significant move by Shanghai state-owned assets in the biopharmaceutical field [1] Group 2 - On August 21, Kanghua Biotech experienced a net inflow of 37.11 million yuan in main funds, accounting for 0.36% of its circulating market value. However, over the past five days, there was a net outflow of 114 million yuan, representing 1.11% of its circulating market value [1]